France· FR:62898420
SIXMO 74,2 mg implant
A medicinal product containing chlorhydrate de buprénorphine, registered in France by MOLTENI & ALITTI.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE BUPRÉNORPHINE
- Manufacturer
- MOLTENI & ALITTI
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550817914 sachet(s) polytéréphtalate (PET) polyéthylène basse densité (PEBD) aluminium de 1 implant(s) avec applicateur(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de buprénorphine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomSixmo 74.2mg implantAccord-UK Ltd
- CzechiaADDNOKI-GEN, LDA, Caparica
- United StatesBELBUCABioDelivery Sciences International Inc
- SwedenBuprefarm 10 mikrogram/timme DepotplåsterOrifarm Generics A/S
- FinlandBupaq Multidose vetVetViva Richter GmbH
- NetherlandsBuprenorfine G.L. Pharma 0,2 mg tabletten voor sublinguaal gebruikG.L. Pharma GmbH
- GermanyAcimaphinLuye Pharma Ag
- BelgiumBuprenorfine Sandoz 35 µg/hSandoz
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Astec, Bupensan
- Belgium · Temgesic, Transtec
- Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
- Cyprus · Buvera
- Czechia · Addnok, Buprenorfin Stada
- Germany · Acimaphin, Acinorphin
- Denmark · Buprefarm, Bupremyl
- Estonia · Buprenorphine G.L. Pharma
- Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
- Finland · Buprefarm, Bupremyl
- United Kingdom (Northern Ireland) · Addnok, Bunov
- Greece · Buprenal, Buvera
- Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
- Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
- Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
- Italy · Buprenorfina Molteni, Buprenorfina Sandoz
- Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
- Luxembourg · Temgesic, Temgesic Sublingualis
- Latvia · Buprenorphine G.L. Pharma
- Malta · Buprenorphine Aspire Pharma (Malta), Natzon
- Netherlands · Buprenorfine, Buprenorfine 1a Pharma
- Norway · Bugnanto, Buprefarm
- Poland · Bunondol, Bunorfin
- Portugal · Buprenorfina, Buprenorfina Aurovitas
- Sweden · Buprefarm, Buprenorfin Actavis
- Slovenia · Addnok, Buprenorfin Alkaloid-Int
- Slovakia · Bupretec, Noprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1819aa4-a580-4374-a29f-e9e88498829d GET /v1/drugs/f1819aa4-a580-4374-a29f-e9e88498829d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62898420",
"date_amm": "2019-06-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/19/1369",
"substance": "CHLORHYDRATE DE BUPRÉNORPHINE",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "implant",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de buprénorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.